Ovulation Induction

descriptionPublicationkeyboard_double_arrow_right Article 01 Mar 2015 English Publisher:Elsevier BVJournal:Obstetrics and Gynecology Clinics of North America, volume 42, pages 27-37 (issn: 0889-8545,

Copyright policy )

Authors: Johanna, Von Hofe; G Wright, Bates;

doi: 10.1016/j.ogc.2014.09.007

pmid: 25681838

Ovulation Induction

- Summary
- Subjects
- Metrics

Abstract

Before initiating ovulation induction, it is important to evaluate the underlying cause of a patient's anovulation and to make lifestyle modifications or treat underlying medical conditions, as appropriate. Here, ovulation induction agents are discussed with attention to their pharmacology, indications for use, therapy regimens, and efficacy. Adjuvant therapies and appropriate monitoring are also reviewed.

Related Organizations

University of Alabama at Birmingham
United States

Keywords

Hypogonadism, Estrogens, Fertility Agents, Female, Clomiphene, Ovulation Induction, Pregnancy, Humans, Female, Progestins, Amenorrhea, Infertility, Female, Gonadotropins, Anovulation, Polycystic Ovary Syndrome

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	16
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average